PortfoliosLab logoPortfoliosLab logo
CPRX vs. WMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CPRX vs. WMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Catalyst Pharmaceuticals, Inc. (CPRX) and Walmart Inc. (WMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CPRX achieves a 34.36% return, which is significantly higher than WMT's 9.07% return. Over the past 10 years, CPRX has outperformed WMT with an annualized return of 46.26%, while WMT has yielded a comparatively lower 19.77% annualized return.


CPRX

1D
-0.03%
1M
0.64%
YTD
34.36%
6M
32.77%
1Y
29.11%
3Y*
39.03%
5Y*
40.44%
10Y*
46.26%

WMT

1D
0.45%
1M
-7.93%
YTD
9.07%
6M
4.13%
1Y
28.71%
3Y*
34.18%
5Y*
22.42%
10Y*
19.77%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CPRX vs. WMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CPRX
Catalyst Pharmaceuticals, Inc.
34.36%11.84%24.15%-9.62%174.74%102.69%-10.93%95.31%-50.90%272.38%
WMT
Walmart Inc.
9.07%24.49%73.99%12.88%-0.46%1.97%23.32%30.16%-3.43%46.56%

Correlation

The correlation between CPRX and WMT is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Nov 8, 2006

0.08

The correlation between CPRX and WMT shifts across timeframes, from -0.06 (1 year) to 0.14 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CPRX:

$3.98B

WMT:

$968.20B

EPS

CPRX:

$1.74

WMT:

$2.88

PE Ratio

CPRX:

18.02

WMT:

42.04

PEG Ratio

CPRX:

0.32

WMT:

2.75

PS Ratio

CPRX:

6.68

WMT:

1.34

PB Ratio

CPRX:

3.93

WMT:

10.26

Total Revenue (TTM)

CPRX:

$596.96M

WMT:

$725.31B

Gross Profit (TTM)

CPRX:

$378.23M

WMT:

$181.16B

EBITDA (TTM)

CPRX:

$313.50M

WMT:

$44.32B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CPRX vs. WMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPRX
CPRX Risk / Return Rank: 6969
Overall Rank
CPRX Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
CPRX Sortino Ratio Rank: 6666
Sortino Ratio Rank
CPRX Omega Ratio Rank: 6666
Omega Ratio Rank
CPRX Calmar Ratio Rank: 7171
Calmar Ratio Rank
CPRX Martin Ratio Rank: 7171
Martin Ratio Rank

WMT
WMT Risk / Return Rank: 7676
Overall Rank
WMT Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
WMT Sortino Ratio Rank: 7373
Sortino Ratio Rank
WMT Omega Ratio Rank: 7474
Omega Ratio Rank
WMT Calmar Ratio Rank: 7575
Calmar Ratio Rank
WMT Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CPRX vs. WMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Walmart Inc. (WMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CPRXWMTDifference
Sharpe ratioReturn per unit of total volatility

-0.33

Sortino ratioReturn per unit of downside risk

-0.39

Omega ratioGain probability vs. loss probability

1.18

1.23

-0.05

Calmar ratioReturn relative to maximum drawdown

1.52

1.83

-0.31

Martin ratioReturn relative to average drawdown

3.46

5.82

-2.37

CPRX vs. WMT - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 0.89, which is comparable to the WMT Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of CPRX and WMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CPRX vs. WMT - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than WMT's maximum drawdown of -77.14%. Use the drawdown chart below to compare losses from any high point for CPRX and WMT.


Loading charts...

Drawdown Indicators


CPRXWMTDifference

Max Drawdown

Largest peak-to-trough decline

-94.25%

-77.14%

-17.11%

Max Drawdown (1Y)

Largest decline over 1 year

-19.18%

-15.75%

-3.43%

Max Drawdown (3Y)

Largest decline over 3 years

-27.29%

-21.93%

-5.36%

Max Drawdown (5Y)

Largest decline over 5 years

-45.37%

-25.74%

-19.63%

Max Drawdown (10Y)

Largest decline over 10 years

-64.87%

-25.74%

-39.13%

Current Drawdown

Current decline from peak

-0.03%

-9.81%

+9.78%

Average Drawdown

Average peak-to-trough decline

-51.96%

-14.63%

-37.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.84%

4.94%

+4.90%

Volatility

CPRX vs. WMT - Volatility Comparison

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.47%, while Walmart Inc. (WMT) has a volatility of 9.86%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than WMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CPRXWMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.47%

9.86%

-9.39%

Volatility (6M)

Calculated over the trailing 6-month period

23.17%

18.49%

+4.68%

Volatility (1Y)

Calculated over the trailing 1-year period

33.28%

23.67%

+9.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.77%

21.68%

+26.09%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.39%

21.73%

+38.66%

Dividends

CPRX vs. WMT - Dividend Comparison

CPRX has not paid dividends to shareholders, while WMT's dividend yield for the trailing twelve months is around 0.80%.


PositionTTM20252024202320222021202020192018201720162015
CPRX
Catalyst Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
WMT
Walmart Inc.
0.80%0.84%0.92%1.45%1.58%1.52%1.50%1.78%2.23%2.07%2.89%3.20%

Financials

CPRX vs. WMT - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Walmart Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B20222023202420252026
149.39M
177.75B
(CPRX) Total Revenue
(WMT) Total Revenue
Values in USD except per share items

CPRX vs. WMT - Profitability Comparison

The chart below illustrates the profitability comparison between Catalyst Pharmaceuticals, Inc. and Walmart Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
25.1%
Portfolio components
CPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.

WMT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Walmart Inc. reported a gross profit of 44.69B and revenue of 177.75B. Therefore, the gross margin over that period was 25.1%.

CPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.

WMT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Walmart Inc. reported an operating income of 7.49B and revenue of 177.75B, resulting in an operating margin of 4.2%.

CPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.

WMT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Walmart Inc. reported a net income of 5.65B and revenue of 177.75B, resulting in a net margin of 3.2%.


Frequently Asked Questions


CPRX and WMT have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WMT has higher volatility (9.86%) compared to CPRX (0.47%). In terms of maximum drawdown, CPRX dropped -94.25% vs WMT's -77.14%.

WMT currently has the higher Sharpe Ratio (1.22 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CPRX and WMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer